New Delhi, Sept. 21 -- Union Minister of State (MoS) for Health and Family Welfare Anupriya Patel on Monday said that patient safety is the top priority of the Government of India as she highlighted the expansion of the country's pharmacovigilance network and announced the launch of the 'Biovigilance Programme of India' (BvPI) to monitor adverse reactions associated with medicines and biological products used in organ and tissue transplants.

Speaking to the media during the 6th National Pharmacovigilance Week, Patel said, "National Pharmacovigilance Week has been organised, and during this, we have released the 7th edition of the National Formulary of India (NFI) along with its digital version."

"Patient safety is the top priority of th...